OW0

(1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate

Created:	2022-05-18
Last modified:	2023-11-22

Find Related PDB Entry
1 entries where OW0 is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	43
Chiral Atom Count	6
Bond Count	46
Aromatic Bond Count	6

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate
Systematic Name (OpenEye OEToolkits)	[(1~{R},2~{R},4~{S},5~{S})-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl] (2~{S})-3-oxidanyl-2-phenyl-propanoate
Formula	C₁₇ H₂₁ N O₄
Molecular Weight	303.353
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	OCC(c1ccccc1)C(=O)OC1CC2N(C)C(C1)C1OC21
SMILES	CACTVS	3.385	CN1[CH]2C[CH](C[CH]1[CH]3O[CH]23)OC(=O)[CH](CO)c4ccccc4
SMILES	OpenEye OEToolkits	2.0.7	CN1C2CC(CC1C3C2O3)OC(=O)C(CO)c4ccccc4
Canonical SMILES	CACTVS	3.385	CN1[C@@H]2C[C@H](C[C@H]1[C@@H]3O[C@H]23)OC(=O)[C@H](CO)c4ccccc4
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)c4ccccc4
InChI	InChI	1.03	InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1
InChIKey	InChI	1.03	STECJAGHUSJQJN-FWXGHANASA-N

Drug Info: DrugBank

DrugBank ID	DB00747
Name	Scopolamine
Groups	approved investigational
Description	Scopolamine is a tropane alkaloid isolated from members of the _Solanaceae_ family of plants, similar to [atropine] and [hyoscyamine], all of which structurally mimic the natural neurotransmitter [acetylcholine].[A228423, A228763] Scopolamine was first synthesized in 1959, but to date, synthesis remains less efficient than extracting scopolamine from plants.[A228763] As an acetylcholine analogue, scopolamine can antagonize muscarinic acetylcholine receptors (mAChRs) in the central nervous system and throughout the body, inducing several therapeutic and adverse effects related to alteration of parasympathetic nervous system and cholinergic signalling.[A228758, L31578] Due to its dose-dependent adverse effects, scopolamine was the first drug to be offered commercially as a transdermal delivery system, Scopoderm TTS®, in 1981.[A228423, A228758] As a result of its anticholinergic effects, scopolamine is being investigated for diverse therapeutic applications; currently, it is approved for the prevention of nausea and vomiting associated with motion sickness and surgical procedures.[A228773, L31578] Scopolamine was first approved by the FDA on December 31, 1979, and is currently available as both oral tablets and a transdermal delivery system.[L31578]
Synonyms	scopine (-)-tropate 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate 6,7-Epoxytropine tropate scopine (−)-tropate (1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester Scopolamine (-)-scopolamine (-)-hyoscine Scopolamine hydrobromide Hyoscine
Brand Names	Scopolamine Trandermal System PB Hyos Donnagel Liq Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide B-Donna Scopolamine Hydrobromide Injection Atenolol Scopolamine Donnatal Extentabs Scopace Quadrapax Diban Cap Isopto Hyoscine Donnatal Elixir Scopolamine Re-PB Hyos Elixir Phenobarbital with Belladonna Alkaloids Donnatal Tab Kimite Se-donna Pb Hyos Scopolamine Hydrobromide Injection USP Donnatal Extentabs Srt Re-PB Hyos Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide Scopolamine Bromide Trihydrate Scopolamine Transdermal System Phenohytro Servira Belladonna Alkaloids with Phenobarbital Phenobarbital With Belladonna Alkaloids Vitetal Transderm Scop Donnatal Belladonna Alkaloids with Phenobartbital Phenobarbital with Belladonna Alkaloids - Mint Propranolol Scopolamine Phenobarbital with Belladonna Alkaloids - Grape Me-PB-Hyos Scopolamine Hydrobromide
Indication	Scopolamine is indicated in adult patients for the prevention of nausea and vomiting associated with motion sickness and for the prevention of postoperative nausea and vomiting (PONV) associated with anesthesia or opiate analgesia.[L31578]
Categories	Adjuvants Adjuvants, Anesthesia Agents producing tachycardia Alimentary Tract and Metabolism Alkaloids Anticholinergic Agents Antiemetics Antiemetics and Antinauseants Antimuscarinics Antispasmodics Autonomic Agents Aza Compounds Azabicyclo Compounds Belladonna Alkaloids Central Nervous System Agents Central Nervous System Depressants Cholinergic Agents Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Substrates Gastrointestinal Agents Hypnotics and Sedatives Muscarinic Antagonists Mydriatics Mydriatics and Cycloplegics Nervous System Neurotransmitter Agents Ophthalmologicals Peripheral Nervous System Agents Psycholeptics Scopolamine Derivatives Sensory Organs Solanaceous Alkaloids Tropanes
ATC-Code	N05CM05 S01FA02 A04AD01 A04AD51
CAS number	51-34-3

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Muscarinic acetylcholine receptor M1	MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISF...	unknown	antagonist
Muscarinic acetylcholine receptor M2	MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKV...	unknown	antagonist
Muscarinic acetylcholine receptor M3	MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFS...	unknown	antagonist
Muscarinic acetylcholine receptor M4	MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGN...	unknown	antagonist
Muscarinic acetylcholine receptor M5	MEGDSYHNATTVNGTPVNHQPLERHRLWEVITIAAVTAVVSLITIVGNVL...	unknown	antagonist
Neuronal acetylcholine receptor subunit alpha-4	MELGGPGAPRLLPPLLLLLGTGLLRASSHVETRAHAEERLLKKLFSGYNK...	unknown	inhibitor,inducer
Neuronal acetylcholine receptor subunit beta-2	MARRCGPVALLLGFGLLRLCSGVWGTDTEERLVEHLLDPSRYNKLIRPAT...	unknown	inhibitor,inducer
Sucrase-isomaltase, intestinal	MARKKFSGLEISLIVLFVIVTIIAIALIVVLATKTPAVDEISDSTSTPAT...	unknown	inhibitor
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682